MARKET

AVDL

AVDL

Avadel Pharmaceu
NASDAQ
21.69
+0.09
+0.42%
After Hours: 21.69 0 0.00% 16:10 02/06 EST
OPEN
21.60
PREV CLOSE
21.60
HIGH
21.70
LOW
21.59
VOLUME
1.08M
TURNOVER
--
52 WEEK HIGH
23.57
52 WEEK LOW
6.38
MARKET CAP
2.13B
P/E (TTM)
-3943.6364
1D
5D
1M
3M
1Y
5Y
1D
Harmony Biosciences Makes The Grade
Seeking Alpha · 4d ago
Weekly Report: what happened at AVDL last week (0126-0130)?
Weekly Report · 5d ago
Weekly Report: what happened at AVDL last week (0119-0123)?
Weekly Report · 01/26 09:47
Avadel Sets Court Date for Alkermes Acquisition Scheme
TipRanks · 01/20 11:37
AVADEL PHARMACEUTICALS- IRELAND HIGH COURT SETS HEARING FOR AVADEL'S SCHEME ON ALKERMES FOR FEB 10, 2026 - SEC FILING
Reuters · 01/20 11:05
Irish Court Sets Date to Sanction Avadel Pharmaceuticals Acquisition by Alkermes
Reuters · 01/20 11:03
Weekly Report: what happened at AVDL last week (0112-0116)?
Weekly Report · 01/19 09:51
Avadel Shareholders Approve Acquisition by Alkermes plc
TipRanks · 01/12 21:32
More
About AVDL
Avadel Pharmaceuticals PLC is a biopharmaceutical company. The Company's product, LUMRYZ, is an extended-release formulation of sodium oxybate, indicated to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. Its approach includes applying solutions to the development of medications that address the challenges patients face with treatment options. Its drug delivery technologies include MICROPUMP, LIQUITIME, and MEDUSA. Its MICROPUMP technology allows for the development of modified-release solid, oral dosage formulations of drugs. Its LIQUITIME technology allows for the development of modified-release oral products in a liquid suspension formulation, which may make such formulations particularly suited for children and/or patients having issues swallowing tablets or capsules. Its MEDUSA technology allows for the development of modified-release injectable dosage formulations of drugs.

Webull offers Avadel Pharmaceuticals PLC (ADR) stock information, including NASDAQ: AVDL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVDL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AVDL stock methods without spending real money on the virtual paper trading platform.